Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Worldwide Amniotic Membrane Industry to 2028 - Featuring Sky Biologics, Integra Lifescience and Surgenix Among Others


DUBLIN, May 17, 2022 /PRNewswire/ -- The "Global Amniotic Membrane Market 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

As per the publisher's report, the global amniotic membrane market is anticipated to advance at a compound annual growth rate of 7.01% in revenue over the forecasted period of 2022-2028.

Factors such as rising awareness of wound care treatment, growing research on stem cell biology and regenerative medicine, and incidents of burn injuries are key factors supplementing the amniotic membrane market.

Additionally, the potential use of an amniotic membrane in tissue engineering application and growth of the ophthalmology segment opens new avenues for the studied market. However, limitations related to amniotic membrane usage negatively impact the global market.

Regional Outlook

The global amniotic membrane market comprises North America, Asia-Pacific, Latin America, Europe, and the Middle East and Africa regions.

Globally, the Asia-Pacific is expected to observe the fastest-growth rate in the region. The region's growth is mainly on account of rising accidents and cosmetic surgery trends. Moreover, the benefits of amniotic membrane in eye surgery open new avenues for the amniotic membrane market. Countries such as China, India, and South Korea have emerged as a key market for amniotic membrane. Furthermore, the growing plastic surgery culture has encouraged the use of amniotic membrane in cosmetic surgery applications. Therefore, as stated above, these factors support the amniotic membrane market's growth across the region.

Competitive Outlook

The major companies in the amniotic membrane market consist of Sky Biologics LLC, Integra Lifescience Corp, Surgenix LLC, Smith and Nephew Plc, Bio Tissue Inc, Organogenesis, Human Regenerative Technologies, Labtician Ophthalmics Inc, Amniox Medical Inc, Katena Products Inc, Amino Technology LLC, Surgilogix LLC, MiMedx, and Celularity Inc.

Integra Lifescience Corp is a leading company in medical technology. It offers advanced solutions in neurosurgery, orthopedic extremity surgery, and advanced wound management. Additionally, the company offers surgical instruments to hospitals, surgery centers, dental offices, and physicians. The company expanded its base regenerative technology to include surgical instruments, neurosurgical products, and orthopedic hardware. Integra offers innovative healthcare solutions through offices across 130 countries across the globe. It is headquartered in the United States.

Key Topics Covered:

1. Global Amniotic Membrane Market - Summary

2. Industry Outlook
2.1. Impact of Covid-19 on Amniotic Membrane Market
2.2. Key Insights
2.2.1. Potential Amniotic Membrane Use to Treat Lung Damages Due to Covid-19
2.2.2. Significant Investments in Research and Development Activities
2.2.3. Growing Healthcare Sector in the Asia-Pacific Region
2.3. Porter'S Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitutes
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Key Market Strategies
2.6.1. Acquisitions
2.6.2. Product Developments
2.6.3. Agreements
2.7. Market Drivers
2.7.1. Rising Awareness of Wound Care Treatment
2.7.2. Growing Research on Stem Cell Biology and Regenerative Medicine
2.7.3. Incidents of Burn Injuries and Traumatic Wounds
2.8. Market Challenge
2.8.1. Limitations Related to Amniotic Membrane Use
2.9. Market Opportunities
2.9.1. Potential Use in Tissue Engineering Applications.
2.9.2. Growth of Ophthalmology Segment

3. Global Amniotic Membrane Market Outlook - by Type
3.1. Cryopreserved Amniotic Membrane
3.2. Lyophilization Amniotic Membrane

4. Global Amniotic Membrane Market Outlook - by Application
4.1. Surgical Wounds
4.2. Ophthalmology
4.3. Other Applications

5. Global Amniotic Membrane Market Outlook - by End-Users
5.1. Hospitals
5.2. Ambulatory Surgical Wounds
5.3. Specialized Clinics
5.4. Research Center & Laboratories

6. Global Amniotic Membrane Market - Regional Outlook

7. Competitive Landscape
7.1. Amino Technology LLC
7.2. Katena Products Inc
7.3. Mimedx
7.4. Bio Tissue Inc
7.5. Surgilogix LLC
7.6. Amniox Medical Inc
7.7. Surgenix LLC
7.8. Labtician Ophthalmics Inc
7.9. Human Regenerative Technologies
7.10. Integra Lifescience Corp
7.11. Smith and Nephew plc
7.12. Organogenesis
7.13. Celularity Inc
7.14. Sky Biologics LLC

8. Research Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/y2eojk

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: